Fundz

Who to call at Virax Biolabs, and when

Fundz watches for the moments Virax Biolabs starts buying, and tells you who to reach.

  • An alert the day Virax Biolabs raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Virax Biolabs, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Virax Biolabs. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Virax Biolabs and Cosmos Health Inc. Extend Exclusive Distribution Agreement for Mpox Virus Real-Time PCR Detection Kits

Sep 16, 2024

Contract Type

agreement

LanarkshireManufacturingBiotechnologyHealth CareTherapeutics

Description

Virax Biolabs Group Limited has extended its existing exclusive distribution agreement with Cosmos Health Inc. to market Mpox Virus Real-Time PCR Detection Kits in Gulf Cooperation Council (GCC) countries. The kits are CE-marked for sale in Europe and also authorized by the Medicines and Healthcare products Regulatory Agency (MHRA). The agreement expands the geographic reach of Virax Biolabs and provides essential tools to diagnose and manage the spread of the Mpox virus.

Company Information

Company

Virax Biolabs

Location

Lanarkshire, Scotland, United Kingdom

About

Virax Biolabs Group Limited is an innovative biotech company founded in 2013 that focuses on detecting immune responses and diagnosing viral diseases, distributing a range of in-vitro diagnostic test kits while developing proprietary T-Cell Test technology aimed at providing an immunology profiling platform to assess individual immune risk against major global viral threats, including COVID-19, Monkeypox, Hepatitis B, Malaria, Herpes, and Human Papillomavirus.

Related People

James
Senior decision-maker at this company
••••••••@••••••••

See James's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Virax Biolabs's next move

Learn about Strategic plan

Virax Biolabs signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.